Danger ahead: COVID-19 infections after vaccination

por Greenberger, Lee M., Nichols, Gwen L.
Publicado 2022

EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors

por Zander, Serge A. L., Sol, Wendy, Greenberger, Lee, Zhang, Yixian, van Tellingen, Olaf, Jonkers, Jos, Borst, Piet, Rottenberg, Sven
Publicado 2012

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

por Greenberger, Lee M., Saltzman, Larry A., Senefeld, Jonathon W., Johnson, Patrick W., DeGennaro, Louis J., Nichols, Gwen L.
Publicado 2021

Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies

por Greenberger, Lee M., Saltzman, Larry A., Senefeld, Jonathon W., Johnson, Patrick W., DeGennaro, Louis J., Nichols, Gwen L.
Publicado 2021

Sars-Cov-2 Antibody Levels in Blood Cancer Patients after a Third Sars-Cov-2 “Booster” Vaccination - Observational Data from the LLS National Registry

por Greenberger, Lee M, Saltzman, Larry A, Senefeld, Jonathon W, Johnson, Patrick W, DeGennaro, Louis J, Nichols, Gwen L
Publicado 2021

Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects

por Sapra, Puja, Kraft, Patricia, Pastorino, Fabio, Ribatti, Domenico, Dumble, Melissa, Mehlig, Mary, Wang, Maoliang, Ponzoni, Mirco, Greenberger, Lee M., Horak, Ivan D.
Publicado 2011

Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies during the Omicron (B.1.1.529) Surge: Data from the Patient-Reported Leukemia & Lymphoma Society National...

por Reddy, Sneha T, Saltzman, Larry A, DeGennaro, Louis J, Nichols, Gwen L, Scott, Janaela, Senefeld, Jonathon W, Johnson, Patrick W, Greenberger, Lee M
Publicado 2022

Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies

por Greenberger, Lee M., Saltzman, Larry A., Gruenbaum, Lore M., Xu, Jun, Reddy, Sneha T., Senefeld, Jonathon W., Johnson, Patrick W., Fields, Paul A., Sanders, Catherine, DeGennaro, Louis J., Nichols, Gwen L.
Publicado 2022

Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer

por Shapiro, Lauren C., Thakkar, Astha, Campbell, Sean T., Forest, Stefanie K., Pradhan, Kith, Gonzalez-Lugo, Jesus D., Quinn, Ryann, Bhagat, Tushar D., Choudhary, Gaurav S., McCort, Margaret, Sica, R. Alejandro, Goldfinger, Mendel, Goel, Swati, Anampa, Jesus D., Levitz, David, Fromowitz, Ariel, Shah, Akash Pradip, Sklow, Charlotte, Alfieri, Gregory, Racine, Andrew, Wolgast, Lucia, Greenberger, Lee, Verma, Amit, Halmos, Balazs
Publicado 2022

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

por Hill, Joshua A., Martens, Michael J., Young, Jo-Anne H., Bhavsar, Kavita, Kou, Jianqun, Chen, Min, Lee, Lik Wee, Baluch, Aliyah, Dhodapkar, Madhav V., Nakamura, Ryotaro, Peyton, Kristin, Shahid, Zainab, Armistead, Paul, Westervelt, Peter, McCarty, John, McGuirk, Joseph, Hamadani, Mehdi, DeWolf, Susan, Hosszu, Kinga, Sharon, Elad, Spahn, Ashley, Toor, Amir A., Waldvogel, Stephanie, Greenberger, Lee M., Auletta, Jeffery J., Horowitz, Mary M., Riches, Marcie L., Perales, Miguel-Angel
Publicado 2023